Calvary Hospital, 91 Rocky Point Road, Kogarah, NSW 2217, Australia; Insulin for Life Global, C/O NHMRC Clinical Trials Centre, 92-94 Parramatta Rd, Camperdown, NSW 2070, Australia.
Insulin for Life Global, C/O NHMRC Clinical Trials Centre, 92-94 Parramatta Rd, Camperdown, NSW 2070, Australia; Department of Chemical Pathology, NSW Pathology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia; Department of Endocrinology, Room 3216, Level 3 West, Charles Perkins Centre D17, Johns, Hopkins Drive, University of Sydney, NSW 2006, Australia.
Diabetes Res Clin Pract. 2022 Jan;183:109153. doi: 10.1016/j.diabres.2021.109153. Epub 2021 Nov 24.
Many nations struggle to provide adequate diabetes care. Legal as well as moral obligations may facilitate access. International human rights law places obligations on governments to ensure the accessibility and affordability of insulin (a World Health Organization essential medicine), and other components of diabetes care. Despite this obligation, the global reality is that access remains deficient. A human rights approach facilitating the improvement of diabetes services and equitable access to insulin provides a strong framework, theoretically and practically, for advocacy and policymaking changes. This approach links governments to their international obligations, fosters the ideal of, and adherence to, national essential medicine lists, complements the pursuit of international goals in non-communicable diseases, and should influence the actions of pharmaceutical and device companies. This approach empowers patients, families, and communities living with diabetes, and grounds actions by governments, clinicians, and non-government organisations in the principles of dignity, non-discrimination, and equity of access.
许多国家在提供足够的糖尿病护理方面都面临困难。法律和道德义务可能会促进获取途径。国际人权法规定各国政府有义务确保胰岛素（世界卫生组织基本药物）和其他糖尿病护理组成部分的可及性和可负担性。尽管有这项义务，但全球的现实情况是，获取途径仍然不足。从理论和实践上看，采取一种促进改善糖尿病服务和公平获取胰岛素的人权方法，为宣传和政策制定改革提供了一个强有力的框架。这种方法将各国政府与其国际义务联系起来，促进对国家基本药物清单的理想信念和遵守，补充对非传染性疾病国际目标的追求，并应影响制药和设备公司的行动。这种方法赋予了糖尿病患者、家庭和社区权力，并使各国政府、临床医生和非政府组织的行动建立在尊严、不歧视和平等获取的原则基础之上。
